Stock Details
GSK is GSK plc's stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 43.78$. Average daily volumn in 3 months 5.7M. Market cap 110.65B

Stock symbol : GSK. Exchange : NYSE. Currency : USD
Lastest price : 43.53$. Total volume : 4.11M. Market state PRE
Click reload if you want to check the lastest price on market!!!

GSK plc (GSK)
Last Price

Previous Close43.77
Day Range42.95-43.63
Bid43.07 x 1.2k
Ask43.08 x 1.8k
Average Volume5.7M
Market Cap110.65B
52 Week Range37.80-46.97
Trailing P/E17.70
Foward P/E12.44
Dividend (Yield %)4.57%
Ex-Dividend Date2022-05-19

Financial Details

According to GSK plc's financial reports the company's revenue in 2021 were 34.11B an decrease(0%) over the years 2020 revenue that were of 34.1B. In 2021 the company's total earnings were 4.38B while total earnings in 2020 were 5.75B(-20%).

Loading ...


GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory... , HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Lyell Immunopharma, Inc.; Novartis; Sanofi SA; Surface Oncology; Progentec Diagnostics, Inc.; Alector, Inc.; and CureVac AG., as well as strategic partnership with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.

Market Cap:
Total Assets:
Total Cash:

News about "GSK plc"


At $43.12, GSK plc (GSK) Is Worth Your Consideration

Source from : stocksregister - 22 hours ago

GSK plc (NYSE:GSK) at last check was buoying at $43.12 on Thursday, June 30, with a fall of -1.50% from its closing price on previous day. Taking a look at stock we notice that its last check on ...See details»


Wealthcare Advisory Partners LLC Has $207,000 Stock Position in GSK plc (NYSE:GSK)

Source from : Defense World - 9 hours ago

Wealthcare Advisory Partners LLC reduced its holdings in shares of GSK plc (NYSE:GSK โ€“ Get Rating) by 5.5% in the 1st quarter, according to its most recent filing with the Securities and Exchange ...See details»

GSK plc (GSK): Does this stock hold the most enticing factor today?

Source from : investchronicle - 2 days ago

GSK plc (GSK) is priced at $43.35 after the most recent trading session. At the very opening of the session, the stock price was $43.59 and reached a high price of $43.75, prior to closing the session ...See details»


GSK plc (NYSE:GSK) Shares Sold by Gofen & Glossberg LLC IL

Source from : Defense World - 4 days ago

Gofen & Glossberg LLC IL decreased its holdings in GSK plc (NYSE:GSK โ€“ Get Rating) by 15.8% during the 1st quarter, HoldingsChannel reports. The institutional investor owned 7,472 shares of the ...See details»

Investment Analystsโ€™ Weekly Ratings Changes for GSK (GSK)

Source from : ETF Daily News - 2 days ago

The company has a quick ratio of 0.94, a current ratio of 1.19 and a debt-to-equity ratio of 147.36. GSK plc has a 52-week low of GBX 1,362.80 ($16.72) and a 52-week high of GBX 1,817 ($22.29). Get ...See details»

A Lesson to Learn: GSK plc (GSK)

Source from : newsheater - 8 days ago

GSK plc (NYSE:GSK) went up by 0.48% from its latest closing price compared to the recent 1-year high of $46.97. The companyโ€™s stock price has collected 1.77% of gains in the last five trading sessions ...See details»


Atticus Wealth Management LLC Purchases 500 Shares of GSK plc (NYSE:GSK)

Source from : ETF Daily News - 4 days ago

Atticus Wealth Management LLC raised its position in shares of GSK plc (NYSE:GSK โ€“ Get Rating) by 69.8% in the first quarter, according to the company in its most recent filing with the SEC. The ...See details»


GSK: Japan Accepts Regulatory Submission For Shingrix To Prevent Shingles In At Risk 18+

Source from : Nasdaq - 3 days ago

Brisith drug major GSK plc (GSK.L) announced Tuesday that Japan's Ministry of Health, Labour and Welfare or MHLW accepts Shingrix (Zoster Vaccine Recombinant, Adjuvanted) regulatory submission to ...See details»


Waiting for a GSK Mega Deal Hurts Like Toothache

Source from : Washington Post - 8 days ago

Reckitt would beย a logical buyer for GSKโ€™s consumer health spinoff Haleon. But the consumer goods giant should be in noย rush.See details»

GSK Selects Target the Future Grant Recipient in Innovation Challenge Supporting Multiple Myeloma Community

Source from : Associated Press - 2 days ago

GSK plc today announced the first recipient of the Target the Future Think Tank Challenge ยฃ70,000 (equivalent to approximately $100,000) grant to the HealthTree Foundation, a non-profit organization ...See details»


GSK Shares Encouraging Data From Chronic Hepatitis B Candidate

Source from : YAHOO!Finance - 4 days ago

GSK plc (NYSE: GSK) announced promising interim results from the B-Clear phase 2b trial of bepirovirsen in people with chronic hepatitis B (CHB). The data showed that bepirovirsen reduced hepatitis B ...See details»

Sanofi-GSK Reports Positive Data From COVID-19 Beta-containing Vaccine Trial

Source from : Nasdaq - 7 days ago

Drug majors Sanofi (SNYNF, SNY) and GSK plc (GSK.L) announced Friday positive data from their vaccine trial which evaluated an adjuvanted bivalent D614 and Beta (B.1.351) vaccine candidate. Sanofi-GSK ...See details»


GSK applies for shingles drug label expansion in Japan

Source from : Proactive Investors - 3 days ago

It wants doctors to be able to prescribe Shingrix to at-risk groups over the age of 18, including those with compromised immune systems ...See details»


Covid-19 Variant Shot From Sanofi, GSK Effective Against Omicron

Source from : Wall Street Journal - 7 days ago

The companies reported promising trial results for their Covid-19 vaccine that showed the shotโ€”developed to target the Beta strain of the virusโ€”was particularly effective against the Omicron variant.See details»